farmakologi-klinik hemodynamic
TRANSCRIPT
Clinical Pharmacology and
HEMODYNAMICS DISORDERS
Sulanto Saleh-Danu R.,MD., SpFK.Dept. of Pharmacology & Therapy
Div.Clinical PharmacologyFac of Medicine, GMU.
21
1
Objective.
After following this lecture to be able to - understand what’s the hemodynamic and hemodynamics
- understand hemodynamics emergency
- understand rational use of medicine (pharmacotherapy) in the situation of hemodynamics emergency
2
HEMODYNAMICS.
Is the study of the relationship between PRESSURE, RESISTANCE and the FLOW of BLOOD in the cardiovasluar system.
( Aaronson, PI. & Ward J P T., 2000)
Is the study of the movement of the blood and the forces concerned there in.
( Doorland’s Illustrated Medical Dictionary, 27th ed., 1988).
Hemodynamic, pertaining to the movementsinvolved in the circulation of the blood.
( Doorland’s Illustrated Medical Dictionary, 27th ed.,1988)
3
(copy from :Aaronson,PI., Ward,J.P.T., 1999)
CO = (MABP-CVP)/ TPR
CO = cardiac output,MABP = mean arterial blood pressure,TPR = total peripheral resistance,CVP = central venous pressure
4
AO = aortaLg. arteries = large arteriesSm.arteries = small arteriesART = arteriolesCAP = capillariesVEN = venuleSV = venousSm veins = small veinsLg veins = large veins
5
HEMODYNAMIC EMERGENCYHEMODYNAMIC EMERGENCY
PRESSURE : - hypertension - hypotension
RESISTANCY : - obtruction of vessel - peripheral vasoconstriction - massive bleeding
FLOW OF THE BLOOD : - blood viscocity - angina/O2 supply 6
HAEMODYNAMICS
PRESSURE
-Hypertension
-Hypotension
- Stroke / CVA - Vital organ damages.
- Shock
RESISTANCE -Vasoconstriction.
-Obstruction
FLOW OF BLOOD -Scleroting of areteries
-Increase of velocity
BLOOD PRESSURE7
ThrombusEmboli
Hematokrit
8
HYPOTENSION HYPOTENSION
SHOCKSHOCK
BLOOD PRESSUREHYPOTENSION
SHOCK organs perfusion
ORGANS / TISSUESDAMAGES
EMERGENCYACTION
9
BLOOD FLOWBLOOD FLOW
ORGANSORGANSPERFUSIONPERFUSION
REVERSEIBLEREVERSEIBLE
IRREVERSIBLEIRREVERSIBLE
CELLULAR / TISSUE / ORGAN CELLULAR / TISSUE / ORGAN INJURY / DAMAGESINJURY / DAMAGES
DEATHDEATH
CRITICAL PERIODE
10
Classification of shock by mechanism and common causes.
Hypovolemic shock
Cardiogenic shock
Obstructive shock
Distributive shock
( Messina, L.M., et al., 2003 ) 11
HypovolemicHypovolemicshockshock
ReducedReducedpreloadpreload
CardiogenicCardiogenicshockshock
ReducedReducedSystolicSystolic
performanceperformance
ObstructiveObstructiveshockshock
Reduced Reduced Ability toAbility to
Fill ventricleFill ventricleIn diastoleIn diastole
DistributiveDistributiveshockshock
SevereSevereMyocardialMyocardialdepressiondepression
Severe Severe Decrease inDecrease in
SystemicSystemicVascularVascular
resistanceresistance
Decrease inDecrease inStroke volumeStroke volume
Decrease in CODecrease in CO HypotensionHypotension
Severe decrease inSevere decrease inTissue & organ blood flowTissue & organ blood flow
Multiple organ system Multiple organ system failurefailure
MaldistributionMaldistributionOf blood flowOf blood flowIn microcircul.In microcircul.
( Parrillo, JE., 1991 )
12
Hypovolemic shock
1. Loss of blood (hemorrhagic shock) - External hemorrhagic : trauma, gastrointestinal bleeding, etc. - Internal hemorrhagic : hematoma, hemothorax, hemoperitoneum.
2. Loss of plasma : burns, exfoliative dermatitis.
3. Loss of fluid and electrolytes - External : vomiting, diarrhea, excessive sweating, hyperosmolar states (diabetic ketoacidosis, nonketotic coma) - Internal ( “third spacing”) : Pancreatitis, Ascites, Bowel obstruction.
13
14
Cardiogenic shock
- Dysrhythmia : - Tachyarrhythmia - Bradyarrhythmia
- “Pump failure” : secondary to myocardial infarction or other cardiomyopathy.
- Acute valvular dysfunction (especially regurgitant lesions )
- Rupture of ventricular septum or free ventricular wall
15
Obstructive shock
- Tension pneumothorax
- Pericardial diseases ( tamponade, constriction)
- Diseases of pulmonary vasculature (massive pulmonary emboli, pulmonary hypertension)
- Cardiac tumor ( atrial myxoma )
- Left atrial mural thrombus
- Obstructive valvular diseases (aortic or mitral stenosis)
16
Distributive shock
- Septic shock
- Anaphylactic shock
- Neurogenic shock
- Vasodilator drugs- Vasodilator drugs
- Acute adrenal insufficiency
17
18
TREATMENT and MANAGEMENT SHOCKTREATMENT and MANAGEMENT SHOCK
1.1. GENERAL MEASURE GENERAL MEASURE : “ ABC “ VENTILATION Oxygen supply Advanced Cardiogenic Life Support (ACLS) Folley Catheter urinary output Laboratory : blood count electrolyt glucose blood gas analyse coagulation parameter blood group bacterial cultur
2.2. CENTRAL VENOUS PRESSURE ( CVP ) orCENTRAL VENOUS PRESSURE ( CVP ) or PULMONARY CAPILLARY WEDGE PRESSURE (PCWP) PULMONARY CAPILLARY WEDGE PRESSURE (PCWP)
19
3. VOLUME REPLACEMENT.3. VOLUME REPLACEMENT. I.V. LINE ( better use TRANFUSION SET ) HEMORRHAGIC SHOCK : HEMORRHAGIC SHOCK : BLOOD SUBSTITUTES / WHOLE BLOOD / PBRC (Packed Blood Red Cells) + isotonic solution preventing increase of Hmt. HYPOVOLEMIC SHOCK HYPOVOLEMIC SHOCK : Rapid bolus ISOTONIC CRISTALLOID 1 L CARDIOGENIC SHOCK :CARDIOGENIC SHOCK : ISOTONIC CRISTALLOID ( smaller volume ) SEPTIC SHOCK SEPTIC SHOCK : Large volume ISOTONIC CRISTALLOID.
SHOCK in TRAUMA CAPITIS SHOCK in TRAUMA CAPITIS HYPERTONIC SALINE (7.5%) plus DEXTRAN.
20
4.4. MEDICATIONSMEDICATIONS 4.1. VASOACTIVE THERAPY 4.1. VASOACTIVE THERAPY : INOTROPIC agents VASOPRESSOR agents - AFTER ADEQUATE FLUID RESUSCITATION - DEPENDS ON CARDIAC OUTPUT AgentsAgents : - Dobutamine - Nor-adrenaline/Nor-epinephrine - Adrenaline/Epinephrine - Dopamine - Vasopressin ( antidiuretic hormon /ADH ) DISTRIBUTIVE/VASODILATOR SHOCK
4.2. CORTICOSTEROID 4.2. CORTICOSTEROID SEPTIC SHOCK 4.3. Activated Protein C 4.3. Activated Protein C as antithrombotic, profibrinolytic and Anti-inflamatory ( SEPTIC SHOCK) 4.4. ANTIBIOTIC4.4. ANTIBIOTIC DEFINITIVE THERAPY in SEPTIC SHOCK 4.5. SODIUM BICARBONATE 4.5. SODIUM BICARBONATE SEPTIC SHOCK with LACTIC ACIDOSIS
DRUGS USED IN DRUGS USED IN NON-CARDIOGENIC SHOCKNON-CARDIOGENIC SHOCK
- Cathecholamines and sympathomimetic amines:Cathecholamines and sympathomimetic amines: adrenaline (epinephrine); noradrenaline (norepinephrine);adrenaline (epinephrine); noradrenaline (norepinephrine); isoprenaline (isoproterenol); dopamine; dobutamine; etc.isoprenaline (isoproterenol); dopamine; dobutamine; etc.
- others :- others : glucagon; naloxone; corticosteroids; etc. glucagon; naloxone; corticosteroids; etc.
First of all : do not forget insert the iv line.First of all : do not forget insert the iv line.
21
PRINCIPLES SHOCK MANAGEMENT :PRINCIPLES SHOCK MANAGEMENT :
1.1. ALLEVIATING THE PRECIPITATING CAUSE OF SHOCK;ALLEVIATING THE PRECIPITATING CAUSE OF SHOCK;
2.2. TREATING THE HAEMODYNAMIC AND TREATING THE HAEMODYNAMIC AND METABOLIC CONSEQUENCES;METABOLIC CONSEQUENCES;
3. MANAGING THE SECONDARY MEDICAL3. MANAGING THE SECONDARY MEDICAL COMPLICATIONS ( renal failure; pulmonary oedema etc.)COMPLICATIONS ( renal failure; pulmonary oedema etc.)
(Benowitz, N.L., et al., 1997)
see lecture: shock managementsee lecture: shock management..
22
23
HYPERTENSIONHYPERTENSION
PREVENTPREVENT
VITAL ORGAN FAILUREVITAL ORGAN FAILURE
24
BLOOD PRESSURE HYPERTENSION
Classification Systolic Diastolic (mmHg) (mmHg)
Normotension (normal) < 120 and/or < 80Prehypertension 120 – 139 and/or 80 – 89 Stage 1 Hypertension 140 – 159 and/or 90 – 99 Stage 2 Hypertension 160 – 179 and/or 100 – 109
Stage 3 ( severe) HT 180 - 209 and/or 110 – 119
Stage 4 (very severe) HT > 210 and/or > 120
( JNC V & VII, 2003)
emergency25
HYPERTENSION CONSEQUENCIESHYPERTENSION CONSEQUENCIES
ORGAN DAMAGES : ORGAN DAMAGES : - KIDNEYS - KIDNEYS eg. Renal Failure eg. Renal Failure - EYES ( RETINA) - EYES ( RETINA) eg. Retinopathia /Blindness eg. Retinopathia /Blindness - BRAIN - BRAIN eg. CVA ( Stroke )/ TIA eg. CVA ( Stroke )/ TIA - HEART - HEART eg. LVH,MI, Heart Failure eg. LVH,MI, Heart Failure
DEATHDEATH26
MANAGEMENT VERY SEVERE HYPERTENSION(HYPERTENSIVE EMERGENGY).
MUST BE BALANCE RISK AND EFFICACY URGENT REDUCTION BP : hypertensive encephalopathy;
acute hypertensive heart failure; dissecting aneurysma; etc.
SHOULD BE HOSPITALIZED INITIAL GOAL : REDUCE BP BY NO MORE THAN 25 % WITHIN
FIRST 2 HOURS; BP:160/100 mmHg within next 2-6 hours until at least 24 hours.
27
PHARMACOTHERAPY.
PARENTERAL : 1. sodium nitroprusside 0.3 microgram /kg/minute iv for 10 minutes then increase/decrease 0.3 microgram/kg/minute every 5-10 minutes reach the maintain BP level.
ALTERNATIVELY,
2 diazoxide 30 mg iv, increase as necessary in 30 – 60 mg bolus dose at 5 to 10 minute interval, up to 300 mg;
3. hydralazine 5 to 10 mg slowly i.v.repeat at 20 minute interval;
4. clonidine 150 – 300 microgram im or slowly iv over 10 minutes
28
LESS URGENT SITUATION:
PHARMACOTHERAPY ORALWhere oral therapy is appropriate, use :
- amlodipine 5 – 10 mg, or - felodipine sustained-release 2.5 – 10 mg, or - nifedipine (tablet) 10 – 20 mg or
- methyldopa 250 – 500 mg, or - prazosin 2 – 5 mg, or - captopril 6.25 mg – 50 mg (not sublinguallly).
29
If MYOCARDIAL ISCHAEMIA is also present :If MYOCARDIAL ISCHAEMIA is also present :
- ß-blockerß-blocker ( with or without : ( with or without : Calcium channelCalcium channel blocker : amlodipine or felodipine SRblocker : amlodipine or felodipine SR ) )
TREATMENT SHOULD BE CONTINUEDTREATMENT SHOULD BE CONTINUED
BP BP TO SATISFACTORY LEVEL TO SATISFACTORY LEVEL
30
PHARMACOTHERAPEUTIC MANAGEMENTOF HYPERTENSION.
CLASS. DIURETICS DIURETICS: - Thiazides, - Loop diuretics, - Potassium-sparring diuretics and aldosterone antagonist, - Osmotic diuretics, - Mercurial diuretics, - Carbonics anhydrase inhibitors, - Diuretics with potassium.
31
-THIAZIDES & THIAZIDE-RELATED DIURETICS. DRUGS : Thiazide : Bendroflumathiazide Benzthiazide Chlorothiazide Hydrochlorothiazide (HCT) Hydroflumethiazide
Related : Chlortalidone Indapamide Xipamide Metolazone.
ADVERSE EFFECTS : - hypokalaemeia, - increased plasma insulin, glucose, cholesterol, hypersensitivity reaction, and impotence.
INDICATIONS : Old ages, Black race congestive heart failure, CONTRAINDICATION : dyslipidaemia.
32
CLASS Beta-receptor Blockers.
Non-selective : propranolol (blocks ß-1&2) nadolol timolol pindolol (also partial ß-receptor agonist)
Selective : metoprolol ( blockß-1 ) atenolol acebutolol (also partial ß-receptor agonist) celiprolol (also partial ß-receptor agonist)
Also block : labetalol α – receptor bucindolol carvidelol
α – receptor : prazosin blockers terazosin doxazosin
33
INDICATIONS : angina, after myocard infarction.INDICATIONS : angina, after myocard infarction. ((αα-receptor blockers : -receptor blockers : diabetes, dyslipidaemia, benign prostaticdiabetes, dyslipidaemia, benign prostatic hypertrophy).hypertrophy).
ADVERSE EVENTS : bronchospasm, fatigue, negative inotropy, CNS ADVERSE EVENTS : bronchospasm, fatigue, negative inotropy, CNS disturbance (nightmares), hypoglycaemia, disturbance (nightmares), hypoglycaemia, dyslipidaemia.dyslipidaemia. ((αα-receptor blockers : postural hypotension,-receptor blockers : postural hypotension, oedema. Less common –urinary incontinence,oedema. Less common –urinary incontinence, dizziness).dizziness).
CONTRAINDICATIONS : asthma bronchiale, diabetes, peripheralCONTRAINDICATIONS : asthma bronchiale, diabetes, peripheral vascular disease, dyslipidaemia. vascular disease, dyslipidaemia.
34
CLASS Ca 2+ - CHANNEL BLOCKERS
nifedipine amlodipine nicardipine isradipine felodipine lacidipine
diltiazem
verapamil
ADV. EVENTS: headache flushing fatigue tachycardia, peripheral oedema bradycardia negative inotropy SA & AV node block with verapamil and diltiazem.
INDICATIONS : angina, renal-insufficiency, cerebrovascular diseases.
CONTRAIDICATIONS : Congestive heart failure, pregnancy, avoid combination with ß-blockers
35
CLASS. ACE (angiotensine converting enzym) INHIBITOR.
captopril INDICATIONS : congestive heart failure, enalapril postmyocardial infarction, diabetes. lisinopril benazepril fosinopril ADVERSE EVENTS : postural hypotension ramipril (first dose), cough, ARF, fatigue, quinapril headache, dizziness, perindopril allergic reactions) trandolipril
CONTRAINDICATIONS : pregnancy, renovascular disease, aortic stenosis.
36
CLASS. A-II RA (Angitensin-II receptor antagonist).
candesartan eprosartan irbesartan losartan olmesartan temilsartan valsartan
INDICATION ~ ACE Inhibitor
ADVERSE EVENTS : almost no cough, rare renal function, electrolytes (must be monitor 1 or 2 weeks after commencing treatment)
CONTRAINDICATION ~ ACEi.
37
CORONARY ISCHAEMIC SYNDROME
SYNDROMES ATTRIBUTABLE TO MYOCARDIAL ISCHAEMIC SECONDARY TO CORONARY OBSTRUCTION.
( PLEASE : ( PLEASE : CARDIOVASCULAR EMERGENCY CARDIOVASCULAR EMERGENCY by dr. LUCIA KRIS DINARTI SpPD, SpJ. ). by dr. LUCIA KRIS DINARTI SpPD, SpJ. ).
Next slide38
39
MANAGEMENT MANAGEMENT (PHARMACOTHERAPY) (PHARMACOTHERAPY) OF STABLE ANGINA) OF STABLE ANGINA)
-Relieve / prevent painRelieve / prevent pain-Slow progression of Slow progression of
atherosclerosisatherosclerosis-Improve prognosisImprove prognosis
ACUTE ATTACK :
-STOP ACTIVITIES-GLYCERYL TRINITRATE spray 400 microgram metered dose sublingually, repeat once after 5’ if pain persists (max of 2 meter dose); OR-GLYCERYL TRINITRATE tablt 300 to 600 microgram s.l. repeat every 3 to 5 minute (max.1800 µg); OR-ISOSORBIDE DINITRATE tablt 5 mg s.l., repeat every 5’ (max. 3 tablt)
WARNING.AVOID NITRATES if the patient has usedsildenafil (Viagra) in the previous 24 hours ORtadalafil (Cialis) in the previous 5 days
CONTINUING THERAPY:
-ASPIRIN 75 to 300 mg p.o. daily OR if intolerant:-CLOPIDOGREL 75 mg daily PLUS EITHER:-ATENOLOL 25 – 100 mg p.o.daily OR-METOPROLOL 25-100 mg p.o. daily 40
MANAGEMENT UNSTABLE ANGINAMANAGEMENT UNSTABLE ANGINA
This CONDITION : is a This CONDITION : is a MEDICAL EMERGENCYMEDICAL EMERGENCY
AGGRESIVEAGGRESIVEPHARMACOTHERAPYPHARMACOTHERAPY
REVASCULARIZATION :REVASCULARIZATION :PTCA or CABGPTCA or CABG
41
DRUGS THERAPY FAILSDRUGS THERAPY FAILSand/orand/or
HIGH RISK MIHIGH RISK MI
REVASCULARIZATION: REVASCULARIZATION:
PTCA PTCA ( PercutaneusTransCoronary Angioplasty )( PercutaneusTransCoronary Angioplasty )CABGCABG (Coronary Artery Bypass Grafting) (Coronary Artery Bypass Grafting)
42
BLOCK : BIOMEDICAL SCIENCES I; II and IIIBLOCK : BIOMEDICAL SCIENCES I; II and III
BLOCK : CIRCULATION and RESPIRATIONBLOCK : CIRCULATION and RESPIRATION
BLOCK : HEMOPOETIC and LYMPHOID DISORDERS;BLOCK : HEMOPOETIC and LYMPHOID DISORDERS; HEMOSTASIS; SHOCKHEMOSTASIS; SHOCK
BLOCK : NEPHROLOGY; UROLOGY and BODY FLUIDBLOCK : NEPHROLOGY; UROLOGY and BODY FLUID
BLOCK : Elective BLOCK : Elective GUIDE TO GOOD PRESCRIBING GUIDE TO GOOD PRESCRIBING
FOR YOUR SELF LEARNING : 0PEN & LEARN AGAIN THIS BLOCK !!!0PEN & LEARN AGAIN THIS BLOCK !!!
43
44